🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
Cystic fibrosis (CF) is the most common fatal inherited condition in Caucas...
Status
Completed
Location
Birmingham Heartlands Hospital
Start Date
2006-01
Trial ID
NCT02994706
Treatments Being Tested
This is a crossover study to determine the possible factors that might be r...
Status
Withdrawn
Location
Liverpool Heart and Chest Hospital
Start Date
2011-03-30
Trial ID
NCT03644199
Treatments Being Tested
This phase II trial examines the use of blood-based biomarkers is to help i...
Status
Recruiting
Location
Mayo Clinic in Arizona
Start Date
2023-02-21
Trial ID
NCT05541016
Treatments Being Tested
The purpose of this study is to assess whether NaF PET/CT scans can be used...
Status
Terminated
Location
University of Wisconsin Carbone Cancer Center
Start Date
2013-05
Trial ID
NCT01816048
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This research project is designed to promote health among first-year colleg...
Status
Completed
Location
University of Minnesota
Start Date
2019-07-31
Trial ID
NCT03930524
The study aim is to monitor, during exercise tests carried out in various c...
Status
Completed
Location
Service de pneumologie
Start Date
2019-02-22
Trial ID
NCT03718780
Treatments Being Tested
A recent pilot study, GLIMPSE (NCT02690168), was recently completed which d...
Status
Completed
Location
Pennington Biomedical Research Center
Start Date
2020-08-19
Trial ID
NCT04430660
Treatments Being Tested